id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
IRS-2026-0002-0002,IRS,IRS-2026-0002,REG-103430-24 NPRM,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2026-01-02T05:00:00Z,2026,1,2026-01-02T05:00:00Z,2026-03-04T04:59:59Z,2026-01-31T13:13:01Z,,1,0,09000064b9115a01
IRS-2026-0002-0001,IRS,IRS-2026-0002,Branded Prescription Drug Fee Regulations,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2026-01-02T05:00:00Z,2026,1,2026-01-02T05:00:00Z,2026-03-04T04:59:59Z,2026-03-04T10:00:17Z,2025-24153,0,0,09000064b911590a